Search Results - "Mertelj, Tonja"

  • Showing 1 - 6 results of 6
Refine Results
  1. 1

    Hi- JAKi -ng Synovial Fibroblasts in Inflammatory Arthritis With JAK Inhibitors by Burja, Blaž, Mertelj, Tonja, Frank-Bertoncelj, Mojca

    Published in Frontiers in medicine (05-05-2020)
    “…The Janus kinase (JAK)-Signal transducer and activator of transcription (STAT) pathway is one of the central signaling hubs in inflammatory, immune and cancer…”
    Get full text
    Journal Article
  2. 2

    IgA Nephropathy in a Patient Treated with Adalimumab by Mertelj, Tonja, Smrekar, Nataša, Kojc, Nika, Lindič, Jelka, Kovač, Damjan

    Published in Case reports in nephrology and dialysis (28-07-2021)
    “…Abstract Immunoglobulin A (IgA) nephropathy (IgAN) is the most common glomerulonephritis worldwide, characterized by IgA deposits in the glomerular mesangium…”
    Get full text
    Journal Article
  3. 3

    Regulation of Monocyte Adhesion and Type I Interferon Signaling by CD52 in Patients With Systemic Sclerosis by Rudnik, Michał, Rolski, Filip, Jordan, Suzana, Mertelj, Tonja, Stellato, Mara, Distler, Oliver, Blyszczuk, Przemysław, Kania, Gabriela

    Published in Arthritis & rheumatology (Hoboken, N.J.) (01-09-2021)
    “…Objective Systemic sclerosis (SSc) is characterized by dysregulation of type I interferon (IFN) signaling. CD52 is known for its immunosuppressive functions in…”
    Get full text
    Journal Article
  4. 4

    Pregnancy After Kidney Transplantation by Kovač, Damjan, Kovač, Luka, Mertelj, Tonja, Steblovnik, Lili

    Published in Transplantation proceedings (01-04-2021)
    “…Pregnancy after kidney transplantation is an uncommon event. In addition to the risk to the child and the mother, pregnancy has a certain risk for the…”
    Get full text
    Journal Article
  5. 5

    CD52 regulates monocyte adhesion and interferon type I signalling in systemic sclerosis patients by Rudnik, Michał, Rolski, Filip, Jordan, Suzana, Mertelj, Tonja, Stellato, Mara, Distler, Oliver, Blyszczuk, Przemysław, Kania, Gabriela

    Published in Arthritis & rheumatology (Hoboken, N.J.) (24-03-2021)
    “…Systemic sclerosis (SSc) is characterised by dysregulation of type I interferon (IFN-I) signalling. CD52 is known for its immunosuppressive functions in…”
    Get full text
    Journal Article
  6. 6